Page 2 - Akili Interactive News Today

Discover the comprehensive landscape of Virtual Clinical Trials, delving into their size, share, and growth analysis. Explore their applications in...

MarkNtel Advisors is dedicated to delivering in-depth & comprehensive market research study. Their reports are known for providing unbiased inform

EndeavorRx is a prescription digital therapeutic approved for the treatment of children with ADHD. EndeavorOTC is a video game app designed to treat ADD symptoms in adults.

The U.S. digital therapeutics market size is estimated to reach $21.46B by 2030, expanding at a CAGR of 33.8% from 2023 to 2030

MIAMI BEACH, Fla. — Administration of Qelbree for up to 1 year showed similar safety, efficacy and tolerability profiles seen in shorter trials with improvement in ADHD symptoms and executive function, according to a study presented here. “The world needs more nonstimulants for ADHD,” Andrew J. Cutler, MD, associate clinical professor in the department of psychiatry, SUNY

As the digital therapeutics industry deals with a lack of reimbursement pathways, companies like Akili Interactive are taking alternate approaches to growth.

After Pear Therapeutics' bankruptcy, experts warn that more failures are coming for the digital-therapeutics industry.

During Venture Connect at HIMSS23, panelists discussed the future of digital therapeutics.

The company has let go of approximately 35% of its workforce.

Earlier this year, the prescription digital therapeutics company said it would put programs related to cognitive health outside of ADHD on hold.